INTENSIFIED CHEMOTHERAPY WITHOUT SCT IN INFANT ALL: RESULTS FROM COG P9407 (Cohort 3)

BACKGROUND: Infants with acute lymphoblastic leukemia (ALL) present with aggressive disease and a poor prognosis. Early relapse within 6–9 months of diagnosis is common. Approximately 75% of infants have MLL-rearranged (MLL-R) ALL with event free survival (EFS) ranging from 20–30%. Children’s Oncolo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pediatr Blood Cancer
Egile Nagusiak: Dreyer, ZoAnn E., Hilden, Joanne M., Jones, Tamekia L., Devidas, Meenakshi, Winick, Naomi J., Willman, Cheryl L., Harvey, Richard C., Chen, I-Ming, Behm, Fred G., Pullen, Jeanette, Wood, Brent L., Carroll, Andrew J., Heerema, Nyla A., Felix, Carolyn A., Robinson, Blaine, Reaman, Gregory H., Salzer, Wanda L., Hunger, Stephen P., Carroll, William L., Camitta, Bruce M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5145261/
https://ncbi.nlm.nih.gov/pubmed/25399948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25322
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak